China has granted “conditional” market approval to a Sinopharm vaccine with a reported 79 percent efficacy rate against Covid-19, health authorities said Thursday, a major stride towards inoculating the world’s largest population. The Sinopharm jab, which has surged ahead of a raft of Chinese competitors during Phase 3 trials, could signal a breakthrough in the … Continue reading China’s first vaccine hustled to market as race to inoculate 1.3bn speeds up